Well at least we still have RX7 in the pipeline, this RX5 will be much cheaper to manufacture than Epidyolex, so at least it wasn't worse..
Ann: EMD-RX5 demonstrates excellent safety and bioavailability, page-5
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.5¢ |
Change
-0.001(2.78%) |
Mkt cap ! $14.31M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.6¢ | 3.5¢ | $20.88K | 595.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 533841 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 237157 | 1 |
View Market Depth
| Last trade - 15.49pm 15/08/2024 (20 minute delay) ? |
| EMD (ASX) Chart |